Group of transport peptides
Our group develops peptide-based carrier systems for delivering novel drug modalities into cells. Advent of personalised medicine requires the application of precision therapeutic agents, which mostly have a high molecular weight, a short half-life in an organism, and very low bioavailability. RNA-based vaccines and other therapeutics are active and efficient only when packed into nanoparticles (NPs) or bound to carriers. The cell penetrating peptides (nCPPs) of new generations condense nucleic acid molecules of various types into uniform nanoparticles that efficiently enter cells and modulate the expression of targeted genes both in tissue culture and in a living organism.
The main directions of our research:
Team:
Margus Pooga, Professor of Chemical Biology, CV
Researchers:
Ly Porosk (ly.porosk@ut.ee)
Geeta Arya (geeta.arya@ut.ee)
PhD Students
Maria Maloverjan (maria.maloverjan@ut.ee) (Cosupervision with Prof. Rebane IBMTM)
Hanna Andla (hanna.andla@ut.ee) (Cosupervision with Prof. Rebane IBMTM)
Students
MSc student Chigozie Chibueze Nkwocha (chigozie.chibueze.nkwocha@ut.ee)
BSc student İrem Ilgın Gümüşoğlu (irem.ilgin@hotmail.com)
Contact:
Margus Pooga
Faculty of Science and Technology
Institute of Technology
Professor of Chemical Biology
Nooruse 1-300
+372 737 4836
https://www.etis.ee/CV/Margus_Pooga/eng/
Microphoto:
Restoration of EGFP expression (green) in HeLa-EGFP reporter cells with a splicing correcting oligonucleotide delivered into cells in nanoparticles consisting of transport peptide PF14 and Ca ions. The nucleus of cells is stained red.